Ewing's sarcoma of jaw bones in adult patients: 10-year experiences in a Paris university hospital

Journal of Cranio-Maxillofacial Surgery

Volumn 36, Issue 8, 2008, Pages 450-455

  Pitak Arnnop, Poramate ^a,b   Bellefqih, Salima ^a,c   Bertolus, Chloé ^a   Chaine, André ^a   Dhanuthai, Kittipong ^d   Gruffaz, Françoise ^a   Bertrand, Jacques Charles ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^d CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

adult; Ewing's sarcoma; jaw bone; Ki 67; outcome; prognosis

Indexed keywords

ANTINEOPLASTIC AGENT; KI 67 ANTIGEN;

ADJUVANT THERAPY; ADULT; ANTIGEN EXPRESSION; ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CASE REPORT; CLINICAL STUDY; EWING SARCOMA; FEMALE; FRANCE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JAW; MALE; MANDIBLE TUMOR; MAXILLA TUMOR; TOOTH PROSTHESIS; UNIVERSITY HOSPITAL;

ADULT; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; JAW NEOPLASMS; KI-67 ANTIGEN; LONGITUDINAL STUDIES; MALE; NEOPLASM RECURRENCE, LOCAL; SARCOMA, EWING'S; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 54349096528     PISSN: 10105182     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcms.2008.06.002     Document Type: Article

References (29)

1. Alves F.A., Pires F.R., De Almeida O.P., Lopes M.A., and Kowalski L.P. PCNA, Ki-67 and p53 expressions in submandibular salivary gland tumours. Int J Oral Maxillofac Surg 33 (2004) 593-597
2. Altman D.G., and Bland J.M. Absence of evidence is not evidence of absence. BMJ 311 (1995) 485
3. Amir G., Issakov J., Meller I., Sucher E., Peyser A., Cohen I.J., et al. Expression of p53 gene product and cell proliferation marker Ki-67 in Ewing's sarcoma: correlation with clinical outcome. Hum Pathol 33 (2002) 170-174
4. Ashley D.J.B. Evan's Histological Appearances of Tumours. 3rd edition (1978), Churchill Livingstone, Edinburgh p. 54-65
5. de Alava E., Panizo A., Antonescu C.R., Huvos A.G., Pardo-Mindan F.J., Barr F.G., et al. Association of EWS-FLI1 type 1 fusion with lower proliferative rate in Ewing's sarcoma. Am J Pathol 156 (2000) 849-855
6. de Alava E., Antonescu C.R., Panizo A., Leung D., Meyers P.A., Huvos A.G., et al. Prognostic impact of P53 status in Ewing sarcoma. Cancer 89 (2000) 783-792
7. Bernstein M., Kovar H., Paulussen M., Randall R.L., Schuck A., Teot L.A., et al. Ewing's sarcoma family of tumors: current management. Oncologist 11 (2006) 503-519
8. Baude-Brogniez A., Baranzelli M.C., Ferri J., Piot B., Demaille M.C., Lecomte-Houcke M., et al. Sarcome d'Ewing des maxillaires. Intérêt d'une prise en charge multidisciplinaire. A propos de 4 cas. Rev Stomatol Chir Maxillofac 100 (1999) 34-37
9. Cattoretti G., Becker M.H., Key G., Duchrow M., Schluter C., Galle J., et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB-1 and MIB-3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168 (1992) 357-363
10. Cotterill S.J., Ahrens S., Paulussen M., Jurgens H.F., Voute P.A., Gadner H., et al. Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. J Clin Oncol 18 (2000) 3108-3114
11. Dahlin D.C. Bone Tumours. 2nd edition (1967), Charles C Thomas Publisher, Illinois p. 186-195
12. Fonseca A.S., Mezzalira R., Crespo A.N., Bortoleto Jr. A.E., and Paschoal J.R. Ewing's sarcoma of the head and neck. Sao Paulo Med J 118 (2000) 198-200
13. Gerdes J., Schwab U., Lemke H., and Stein H. Production of a monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31 (1983) 13-20
14. Iatropoulos M.J., and Williams G.M. Proliferation markers. Exp Toxicol Pathol 48 (1996) 175-181
15. Kurokawa H., Zhang M., Matsumoto S., Yamashita Y., Tanaka T., Tomoyose T., et al. The relationship of the histologic grade at the deep invasive front and the expression of Ki-67 antigen and p53 protein in oral squamous cell carcinoma. J Oral Pathol Med 34 (2005) 602-607
16. Lothaire P., de Azambuja E., Dequanter D., Lalami Y., Sotiriou C., Andry G., et al. Molecular markers of head and neck squamous cell carcinoma: promising signs in need of prospective evaluation. Head Neck 28 (2006) 256-269
17. Magdelenat H. Tumour markers in oncology: past, present and future. J Immunol Methods 150 (1992) 133-143
18. Myoung H., Kim M.J., Lee J.H., Ok Y.J., Paeng J.Y., and Yun P.Y. Correlation of proliferative markers (Ki-67 and PCNA) with survival and lymph node metastasis in oral squamous cell carcinoma: a clinical and histopathological analysis of 113 patients. Int J Oral Maxillofac Surg 35 (2006) 1005-1010
19. Neville B.W., Damm D.D., Allen C.M., and Bouquot J.E. Oral and Maxillofacial Pathology. 2nd edition (2002), WB Saunders, Philadelphia p. 581-582
20. de Paula A.M., Carvalhais J.N., Domingues M.G., Barreto D.C., and Mesquita R.A. Cell proliferation markers in the odontogenic keratocyst: effect of inflammation. J Oral Pathol 29 (2000) 477-482
21. Pich A., Chiusa L., and Navone R. Prognostic relevance of cell proliferation in head and neck tumours. Ann Oncol 15 (2004) 1319-1329
22. Regezi J.A., and Scuibba J.J. Oral Pathology. Clinical Pathologic Correlations. 2nd edition (1999), WB Saunders, Philadelphia p. 407-409
23. Rodriguez-Galindo C., Spunt S.L., and Pappo A.S. Treatment of Ewing sarcoma family of tumors: current status and outlook for the future. Med Pediatr Oncol 40 (2003) 276-287
24. Sneige N., and Batsakis J.G. Ewing's sarcoma of bone and soft tissues. Ann Otol Rhinol Laryngol 98 (1989) 400-402
25. Sollazzo M.R., Benassi M.S., Magagnoli G., Gamberi G., Molendini L., Ragazzini P., et al. Increased c-myc oncogene expression in Ewing's sarcoma: correlation with Ki-67 proliferation index. Tumori 85 (1999) 167-173
26. Talesh K.T., Motamedi M.H., and Jeihounian M. Ewing's sarcoma of the mandibular condyle: report of a case. J Oral Maxillofac Surg 61 (2003) 1216-1219
27. Tumuluri V., Thomas G.A., and Fraser I.S. Analysis of the Ki-67 antigen at the invasive tumour front of human oral squamous cell carcinoma. J Oral Pathol Med 31 (2002) 598-604
28. Wexler L.H., DeLaney T.F., Tsokos M., Avila N., Steinberg S.M., Weaver-McClure L., et al. Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors. Cancer 78 (1996) 901-911
29. Yalcin S., Turoglu H.T., Ozdamar S., Sadikoglu Y., Gurbuzer B., and Yenici O. Ewing's tumor of the mandible. Oral Surg Oral Med Oral Pathol 76 (1993) 362-367